Zobrazeno 1 - 10
of 430
pro vyhledávání: '"Jens Bedke"'
Autor:
Anne T. Nies, Jörg König, Patrick Leuthold, Katja Damme, Stefan Winter, Mathias Haag, Satohiro Masuda, Stephan Kruck, Hannelore Daniel, Britta Spanier, Martin F. Fromm, Jens Bedke, Ken-ichi Inui, Matthias Schwab, Elke Schaeffeler
Publikováno v:
Pharmacological Research, Vol 196, Iss , Pp 106941- (2023)
Solute carrier (SLC) transport proteins are fundamental for the translocation of endogenous compounds and drugs across membranes, thus playing a critical role in disease susceptibility and drug response. Because only a limited number of transporter s
Externí odkaz:
https://doaj.org/article/a586ce376abb4a7f9f1e1058fa095696
Autor:
Florian A. Büttner, Stefan Winter, Viktoria Stühler, Steffen Rausch, Jörg Hennenlotter, Susanne Füssel, Stefan Zastrow, Matthias Meinhardt, Marieta Toma, Carmen Jerónimo, Rui Henrique, Vera Miranda-Gonçalves, Nils Kröger, Silvia Ribback, Arndt Hartmann, Abbas Agaimy, Christine Stöhr, Iris Polifka, Falko Fend, Marcus Scharpf, Eva Comperat, Gabriel Wasinger, Holger Moch, Arnulf Stenzl, Marco Gerlinger, Jens Bedke, Matthias Schwab, Elke Schaeffeler
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-19 (2022)
Abstract Background Renal cell carcinoma (RCC) is a heterogeneous disease comprising histologically defined subtypes. For therapy selection, precise subtype identification and individualized prognosis are mandatory, but currently limited. Our aim was
Externí odkaz:
https://doaj.org/article/876bc134c9284335b9606279982c1274
Autor:
Florian Hagen, Felix Peisen, Jakob Spogis, Antonia Mair, Konstantin Nikolaou, Arnulf Stenzl, Stephan Kruck, Jens Bedke, Sascha Kaufmann, Wolfgang M. Thaiss
Publikováno v:
Cancer Imaging, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background This study aims at describing the imaging features of the metastatic presentation of clear cell renal cell carcinoma (ccRCC) in arterial (AP) and portal venous phase (PVP) of contrast-enhanced-computed-tomography (CECT) during cli
Externí odkaz:
https://doaj.org/article/95cb53940c9b488998b9af8703becab5
Autor:
Nora Tabea Sibert, Tobias Kurth, Clara Breidenbach, Simone Wesselmann, Günther Feick, Ernst-Günter Carl, Sebastian Dieng, Mohamad Hatem Albarghouth, Atiqullah Aziz, Stefan Baltes, Elisabeth Bartolf, Jens Bedke, Andreas Blana, Marko Brock, Stefan Conrad, Christopher Darr, Florian Distler, Konstantinos Drosos, Gregor Duwe, Amr Gaber, Markus Giessing, Nina Natascha Harke, Axel Heidenreich, Sameh Hijazi, Andreas Hinkel, Björn Theodor Kaftan, Shatlyk Kheiderov, Thomas Knoll, Gerd Lümmen, Inga Peters, Bülent Polat, Valentin Schrodi, Jens-Uwe Stolzenburg, Zoltan Varga, Julius von Süßkind-Schwendi, Vahudin Zugor, Christoph Kowalski
Publikováno v:
PLoS ONE, Vol 18, Iss 12 (2023)
Externí odkaz:
https://doaj.org/article/5e3d756748774f7b862125818bea4512
Autor:
Dennis Gürgen, Michael Becker, Mathias Dahlmann, Susanne Flechsig, Elke Schaeffeler, Florian A. Büttner, Christian Schmees, Regina Bohnert, Jens Bedke, Matthias Schwab, Johann J. Wendler, Martin Schostak, Burkhard Jandrig, Wolfgang Walther, Jens Hoffmann
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Renal cell carcinoma (RCC) is a kidney cancer with an onset mainly during the sixth or seventh decade of the patient’s life. Patients with advanced, metastasized RCC have a poor prognosis. The majority of patients develop treatment resistance towar
Externí odkaz:
https://doaj.org/article/7ac4640177bd4ea9bb1cc13c5cadf092
Autor:
Anna Reustle, Lena‐Sophie Menig, Patrick Leuthold, Ute Hofmann, Viktoria Stühler, Christian Schmees, Michael Becker, Mathias Haag, Verena Klumpp, Stefan Winter, Florian A. Büttner, Steffen Rausch, Jörg Hennenlotter, Falko Fend, Marcus Scharpf, Arnulf Stenzl, Jens Bedke, Matthias Schwab, Elke Schaeffeler
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 6, Pp n/a-n/a (2022)
Abstract Background The metabolic enzyme nicotinamide‐N‐methyltransferase (NNMT) is highly expressed in various cancer entities, suggesting tumour‐promoting functions. We systematically investigated NNMT expression and its metabolic interaction
Externí odkaz:
https://doaj.org/article/9033f25c01264368bb3a1e6cc5f4da53
Autor:
Moritz Maas, Aymone Kurcz, Jörg Hennenlotter, Marcus Scharpf, Falko Fend, Simon Walz, Viktoria Stühler, Tilman Todenhöfer, Arnulf Stenzl, Jens Bedke, Steffen Rausch
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5227 (2023)
C-X-C Motif Chemokine Receptor 4 (CXCR4) is part of the human chemokine system and involved in progression and metastasis in renal cell carcinoma (RCC). However, the role of CXCR4 protein expression in RCC remains controversial. In particular, data r
Externí odkaz:
https://doaj.org/article/a97e33eed18b4c2a9685acd483d4b9ca
Autor:
Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, Annika Nelde, Juliane S. Walz, Stefan Winter, Siahei Kandabarau, Florian Büttner, Mathias Haag, Linus Backert, Daniel J. Kowalewski, Steffen Rausch, Jörg Hennenlotter, Viktoria Stühler, Marcus Scharpf, Falko Fend, Arnulf Stenzl, Hans-Georg Rammensee, Jens Bedke, Stefan Stevanović, Matthias Schwab, Elke Schaeffeler
Publikováno v:
Genome Medicine, Vol 12, Iss 1, Pp 1-24 (2020)
Abstract Background Clear cell renal cell carcinoma (ccRCC) is the dominant subtype of renal cancer. With currently available therapies, cure of advanced and metastatic ccRCC is achieved only in rare cases. Here, we developed a workflow integrating d
Externí odkaz:
https://doaj.org/article/fc55be784afc4fe685c251765eeb65fb
Autor:
Niklas Harland, Mohammed Alfarra, Eva Erne, Moritz Maas, Bastian Amend, Jens Bedke, Arnulf Stenzl
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 3, p 791 (2023)
Background: The retzius-sparing approach for robotic-assisted radical prostatectomy (RARP) has been increasingly adopted. Symptomatic lymphoceles are a widespread complication of RARP with pelvic lymph node dissection. Here, we present a new techniqu
Externí odkaz:
https://doaj.org/article/9db7ade33fad496697a7b696a3fa5bcc
Autor:
Christian Doehn, Martin Bögemann, Viktor Grünwald, Manfred Welslau, Jens Bedke, Martin Schostak, Thomas Wolf, Rainer Ehneß, Elisa Degenkolbe, Stefanie Witecy, Peter J. Goebell
Publikováno v:
Cancers, Vol 14, Iss 22, p 5486 (2022)
The approval of tyrosine kinase inhibitors and checkpoint inhibitors represented a remarkable progression in the therapeutic landscape for the treatment of metastatic renal cell carcinoma (mRCC). Yet, in the ever-evolving landscape of mRCC treatment,
Externí odkaz:
https://doaj.org/article/058ef8f588a644b9979cacec6846e99e